CoChat

Pulmonary Medication Adherence and Health-care Use in Cystic Fibrosis

The DOI matches its Crossref record; 28 of the 28 references it cites were found in a registry or an index.

Abstract

Background Poor treatment adherence is common in cystic fibrosis (CF) and may lead to worse health outcomes and greater health-care use. This study evaluated associations of adherence to pulmonary medications, age, health-care use, and cost among patients with CF. Methods Patients with CF aged ≥ 6 years were identified in a national commercial claims database. A 12-month medication possession ratio (MPR) was computed for each pulmonary medication and then averaged for a composite MPR (CMPR) for each patient. The CMPR was categorized as low ( Results Mean CMPR for the sample (N = 3,287) was 48% ± 31%. Age was inversely related to CMPR. In the concurrent year, more CF-related hospitalizations were observed among patients with low (event rate ratio [ERR], 1.35; 95% CI, 1.15-1.57) and moderate (ERR, 1.25; 95% CI, 1.05-1.48) vs high adherence; similar associations were observed for all-cause hospitalizations and CF-related and all-cause acute care use (hospitalizations + ED) in the concurrent and subsequent year. Rates of CF-related and all-cause outpatient visits did not differ by adherence. Low and moderate adherence predicted higher concurrent health-care costs by $14,211 ($5,557-$24,371) and $8,493 (-$1,691 to $19,709), respectively, compared with high adherence. Conclusions Worse adherence to pulmonary medications was associated with higher acute health-care use in a national, privately insured cohort of patients with CF. Addressing adherence may reduce avoidable health-care…

Overview

Integrity signals

Registry

Crossref · 10.1378/chest.13-1926

Cites

28 of 28 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 28 references

Research works printed but not linked: 2

  1. Pressler, 2011, Aztreonam for inhalation solution, an aerosolized antibiotic for the treatment of pseudomonal airway infection in patients with cystic fibrosis, US Res Dis, 7, 107
  2. Quinn, 2004, Measuring, predicting and improving adherence to inhalation in patients with CF: a randomised controlled study of motivational interviewing [abstract], Pediatr Pulmonol, 38, 360

Cited by

See all 251

Metadata

Authors
Quittner, A. L., Zhang, J., Marynchenko, M., Chopra, P. A., Signorovitch, J., Yushkina, Y., & Riekert, K. A.
Affiliations
  • University of Miami (US)
  • Novartis (United States) (US)
  • Analysis Group (United States) (US)
  • Johns Hopkins University (US)
Corresponding author
Quittner, Alexandra L.
Venue
Chest
Publisher
Elsevier BV
Published
2014-07
Volume
146
Issue
1
Pages
142-151
ISSN
0012-3692 (ISSN-L)
OpenAlex
W2070450626
Cited by
250
References
28
Citations by year
2026: 11 · 2025: 12 · 2024: 11 · 2023: 24 · 2022: 28 · 2021: 20 · 2020: 29 · 2019: 23 · 2018: 20 · 2017: 28 · 2016: 15 · 2015: 22 · 2014: 6
FWCI
24.29
Type
journal article
Language
en
Open access
closed
Licence
  • www.elsevier.com/tdm/userlicense/1.0/ (tdm)
  • www.elsevier.com/legal/tdmrep-license (tdm)
Locations
  • CHEST Journal (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Family Practice › Medication Adherence and Compliance
  • Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Cystic Fibrosis Research Advances
  • Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Inhalation and Respiratory Drug Delivery
Keywords
cystic fibrosis, medication adherence, medication possession ratio, health care utilization, hospitalization, health care costs, outpatient visits, emergency department visits, age, privately insured patients
MeSH terms
Adolescent, Adult, Child, Cystic Fibrosis, Delivery of Health Care, Female, Follow-Up Studies, Humans, Immunosuppressive Agents, Male, Patient Compliance, Retrospective Studies, Health Care Costs, Disease Management, Medication Adherence, Young Adult

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Pulmonary Medication Adherence and Health-care Use in Cystic Fibrosis. https://app.cochat.ai/papers/10.1378/chest.13-1926
The paper
Quittner, A. L., Zhang, J., Marynchenko, M., Chopra, P. A., Signorovitch, J., Yushkina, Y., & Riekert, K. A. (2014). Pulmonary Medication Adherence and Health-care Use in Cystic Fibrosis. Chest. https://doi.org/10.1378/chest.13-1926

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.